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ABSTRACT
In Saccharomyces cerevisiae, RNA polymerase II
assembly is probably initiated by the formation of
the RPB3–RPB11 heterodimer. RPB3 is encoded by a
singlecopygeneintheyeast,mouseandhumangen-
omes. The RPB11 gene is also unique in yeast and
mouse, but in humans a gene family has been identi-
fied that potentially encodes several RPB11 proteins
differing mainly in their C-terminal regions. We com-
paredtheabilitiesofbothyeastandhumanproteinsto
heterodimerize. We show that the yeast RPB3/RPB11
heterodimercriticallydepends on thepresenceofthe
C-terminal region of RPB11. In contrast, the human
heterodimer tolerates significant changes in RPB11
C-terminus, allowing two human RPB11 variants to
heterodimerizewiththesameefficiencywithRPB3.In
keepingwiththisobservation,theinteractionsbetween
the conserved N-terminal ‘a-motifs’ is much more
important for heterodimerization of the human sub-
units than for those in yeast. These data indicate that
the heterodimerization interfaces have been modified
during the course of evolution to allow a recent diver-
sification of the human RPB11 subunits that remains
compatible with heterodimerization with RPB3.
INTRODUCTION
The assembly of the RNA polymerase II (RNAP II) multipro-
tein complex is still poorly understood. It has been established
in theeubacterialmodelthat itsinitial step isthe formationofa
homodimer of the alpha subunit (1). The eukaryotic counter-
part of this homodimer appears to be a heterodimer that com-
prises, in the case of Saccharomyces cerevisiae, the subunits
encoded by the RPB3 and RPB11 genes, henceforth referred to
as Sc3 and Sc11 subunits, respectively (2,3).
In the yeast genome all RNAP II subunits, including Sc3
and Sc11, are encoded by unique genes. While the mouse
genome also contains single RPB3 and RPB11 genes, the
situation is different in the human genome: in contrast to
the RPB3 gene (encoding subunit Hs3) which is unique, a
family of RPB11 genes was identiﬁed [(4), Table 1]. In the
present study we shall consider only two members of this gene
family, RPB11a and RPB11b. The RPB11a gene is the pre-
dominantly transcribed gene in all human cells and tissues
tested so far. Its unique transcript encodes the Hs11a protein
that is found in RNAP II from all cells analysed to date. The
RPB11b gene yields several mRNAs resulting from alternative
splicing processes, which can be detected ubiquitously in
human cells as well. Whether these mRNAs are translated
at all in vivo remains to be established (4). In this study,
we shall consider only the Hs11ba isoform, although other
isoforms have been described (see Table 1 and Discussion).
The structure of the yeast RNAP II has been solved at
atomic resolution (2,5), and is widely considered as a repres-
entative model for all eukaryotic RNAP IIs, including the
human RNAP II. This assumption is supported not only by
sequence homologies but also by the observation that a num-
ber of human RNAP II subunits are indeed able to functionally
replace their yeast counterparts (6,7). Nevertheless, the alpha-
like subunits Hs3 and Hs11a constitute a notable exception,
since they cannot substitute for their yeast homologs (4).
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doi:10.1093/nar/gki672In an attempt to explain this lack of complementation, we
performed a detailed genetic analysis of the RPB3/RPB11
heterodimerization process both in human and yeast systems.
Among the various methods available, we chose the two-
hybrid assay in S.cerevisiae, which should be optimal for
assaying Sc3 and Sc11 yeast proteins. The main limitation
of this method is that fusion proteins have to be used instead
of the endogenous subunits. It may be stressed, however, that
the yeast fusion proteins, LexA-Sc11 and VP16-Sc3, were
found to be functional in vivo since they were able to restore
viability to yeast deleted for these essential genes (strains
YGVS-072 and D138-1d, respectively, see Supplementary
Table 2), after chase of the balancer plasmid (data not
shown). Hence, we inferred that these proteins must be able to
interact in a way closely mimicking the endogenous subunits.
We show here that this ability to interact extends to homo-
logous human subunits. Our analysis, however, is based on the
comparison of effects of similar mutations affecting the pro-
ducts of orthologous genes which are valid only if using the
same interaction assay. When analysing the results, one should
keep inmind thatthe levels ofinducedb-galactosidase activity
represent an indirect measurement of the efﬁciency of the
heterodimer formation in vivo, which cannot be formally
correlated with an afﬁnity constant.
Our results provide the ﬁrst direct evidence that this initial
step in the RNAP II assembly process has signiﬁcantly
diverged, allowing the human RPB11 C-terminal domain to
be diversiﬁed without affecting the stability of the complex,
while the integrity of its yeast counterpart appears to be essen-
tial. The new alleles of RPB11 genes present in the human
genome, therefore, encode proteins that potentially exhibit
human-speciﬁc functions within the RNAP II complex.
MATERIALS AND METHODS
Plasmid construction and mutagenesis
Derivatives were obtained using standard molecular cloning
procedures from four basic plasmid constructs (see Supple-
mentary Table 2).
The pLex vector was modiﬁed from the 2 mm origin-
containing pBTM116 yeast vector, that allows the expression
ofLexA-fusedproteins(8),bytheinsertionofuniqueXhoIand
BamHI restriction sites after the unique EcoRI cloning site.
The pVP vector was modiﬁed from pVP16, a 2 mm origin-
containing yeast vector allowing the expression of VP16-fused
proteins (8), by the insertion of NheI, SpeI, AvrII and XbaI
restriction sites after the unique BamHI cloning site.
The pGEN vector, a 2 mm origin-containing plasmid exhib-
iting an expression cassette driven by a PGK promoter (6), was
used to insert the coding sequence of interest into a unique
NheI restriction site.
The pCM vector, which exhibits a centromeric replication
origin and an ADH1 promoter-driven expression cassette, was
used to insert the sequences of interest between unique XhoI
and BamHI restriction sites [pCM185, (9)].
Each wild-type RNAP II subunit coding sequence was
modiﬁed by Taq polymerase-mediated ampliﬁcation using
appropriate primers, so as to be cloned either into the NheI
site of pVP or pGEN, or between the XhoI and BamHI sites of
pLex or pCM (see Supplementary Table 2).
Deletion mutants were similarly obtained by Taq
polymerase-mediated ampliﬁcation, using the appropriate
primers (see Supplementary Table 2).
Site directed mutagenesis of the various coding sequences
was performed by the Pfu-mediated ampliﬁcation of plasmids,
using mispaired oligonucleotide primers (Stratagen).
RandommutagenesiswasperformedbytreatingpVPSc3and
pVP Hs3 plasmids with 40 mM hydroxylamin at 37C over-
night,beforetransformingEscherichiacoli(DH5astrain).The
resulting libraries consisted of 100 000 independent clones.
Individual clones were obtained after screening in yeast, and
theirsequencesweredeterminedafterrecoverybyelectropora-
tion of the yeast extracts into the DH5a strain of E.coli.
Two hybrids assay
The L40 yeast strain [ade2, trp1-901, leu2-3,112, his3D200,
LYS2::(LexAop)4HIS3, URA3::(LexAop)8lacZ, (8)] was trans-
formed by electroporation in 1 M sorbitol, 50 mM HEPES,
pH 7.5, at 1.6 kV, (4.5 s). The resulting transformants were
selectedon YNB minimalmedium supplemented with adenine
(40 mg/ml), histidine (20 mg/ml), and either leucine (60 mg/ml)
or tryptophan (40 mg/ml), depending on the vector used.
Independent colonies were isolated for further analysis.
The ﬁnal yeast transformants were analysed for the induced
b-galactosidase activity. A qualitative assay was performed
using X-gal conversion as described (10). The activities were
quantiﬁed after inoculation of the transformants into 15 ml
YNB HA liquid medium: the cells were harvested at an OD600
ranging from 0.6 to 1.0, resuspended in 300 ml of Z buffer
(60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM
MgSO4, pH 7.0) and broken using glass beads; the extracts
were clariﬁed by centrifugation and their ONPG cleavage
activity was determined at 20C in buffer Z, in the pre-
sence of 4 mg/ml ONPG. The activities, corrected for
Table 1. The human POLR2J gene family
Gene Genbank accession No Chromosomal
location
cDNA Genbank accession No
hRPB11a NC_000007 [101 679 870–101 674 430] 7q22 hRPB11a AA937330, X98433, X82385
hRPB11b NC_000007 [101 872 683–101 841 531] 7q22 hRPB11ba
hRPB11bb
CR596358, CR614811, CR606303,
AX405711, AJ277739
AJ277740, R85011
hRPB11c NC_000007 [101 773 636–101 742 353] 7q22 hRPB11ca
hRPB11cb
hRPB11cg
AJ277741
AA306683
AF468111
hRPB11d NC_000007 [43 799 592–43 768 503] 7p13 hRPB11dg BC017250, AL526460, AL554541
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mOD420.mg
1.min
1.
Complementation assay
The YGVS072 yeast strain is deleted for the essential RPB11
gene (see Supplementary Table 2), this deletion being com-
pensated by the presence of a plasmid containing the RPB11
gene and a URA3 marker. Both pGEN and pCM derivatives
(see Supplementary Table 2) were independently transformed
in the YGVS072 strain, using a tryptophan auxotrophy selec-
tion. After transformation, the balancer plasmid was chased
in the presence of 5FOA. Yeast cells, when viable, were fur-
ther analysed for their growth rates and thermo- or cryo-
sensitive phenotypes.
RESULTS
Sequence conservation
Comparison of the peptide sequences of Sc11 and Hs11a
revealed a 45% identity between the two proteins (Figure 1A).
The RPB11 encoded subunits are, therefore, moderately
conserved, since this score ranges from 31 to 73% when con-
sidering the other RNAP II subunits. The alignment of the
alpha-like subunits of various RNA polymerases shows a con-
served peptidic motif, the ‘a-motif’, boxed in Figure 1A. This
motif happens to overlap with an alpha helix within the (3D)
structure established for the yeast RNAP II (Figure 1C), as
indicated above the sequence (Figure 1A). The human isoform
Hs11ba differs from the main Hs11a isoform by the exon 4
encoded peptide, as shown by the coloured residues in
Figure 1A. In addition, the Hs11ba protein is lacking
Lys17 when compared to Hs11a (Figure 1A).
The comparison between the Sc3 protein and its Hs3
homolog yielded a 42% identity score (Figure 1B). The
RPB3-encoded subunits are, therefore, also moderately con-
served. The ﬁrst N-terminal alpha helix of this polypeptide
was also noticed to exhibit some homology with the eubac-
terial alpha subunit (data not shown). While Sc3 and Hs3 are
homologous until residue Q268 in Hs3, Hs3 lacks a C-terminal
peptide present in Sc3 (268–318). The 3D structure of this
peptide could not be resolved (Figure 1C) (2,5).
Figure 1. StructureofyeastandhumanRPB11andRPB3subunits.(A) AlignmentofthepeptidicsequencesofSc11,Hs11aandHs11ba.Thehomologiesbetween
the yeast and human polypeptides are shown, vertical bars and dots indicating the identical and the similar residues, respectively. Conserved element (a-motif)
initiallynoticedbycomparingthealphasubunitsofprocaryotesisboxed(18,19).Theresidueshighlightedinyellowweresubjectedtositedirectedmutagenesis(see
text). The secondary structure elements previously described [1ENO PDB structure, (5), see (C)] are schematically shown above the Sc11 sequence with the alpha
helixesandthebetasheetsrepresentedasyellowboxesandbluearrows,respectively.(B)AlignmentofthepeptidicsequencesofSc3andHs3.Themainfeaturesare
pointedasinpanel1A.SimilarlyarethestructureelementsshownabovetheSc3sequence.Thepositionofazincbindingdomain(ZnBD)isshown.(C)3Dviewof
theyeastSc3/Sc11heterodimer(5).TheredandyellowribbonsrepresenttheSc3andSc11polypeptides,respectively,withtheircorrespondingtheN-andC-terminal
ends positioned. The Zn atom (in blue) coordinated by four Cys residues of the Zn BD of Sc3 is also shown.
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resolved within the 10-subunit complex, suggests that the two
proteins mainly heterodimerize via their two N-terminal alpha
helices, as well as their respective C-terminal alpha helices
(Figure 1C). The structure of the human heterodimer has not
been resolved so far.
Interaction analysis
Hs3 and Sc11 do not interact. Sc11/Sc3, Hs11a/Hs3 and
Hs11ba/Hs3 heterodimers were readily detectable using the
two-hybrid system (Figure 2, lines 1, 12 and 20). The b-
galactosidase activities measured in yeast extracts expressing
these combinations were very close, suggesting that the three
heterodimers exhibit similar stabilities within these cells.
Indeed, the overexpressed fused proteins were detectable at
similar levels as judged by western blot (data not shown).
By contrast, while formation of both Hs11a/Sc3 and
Hs11ba/Sc3 heterodimers was readily detectable (Figure 2,
lines 9 and 17), the association of Sc11 and Hs3 could not be
revealed (line 4), as there is no production of any detectable
b-galacosidase activity in the cells. Since both Sc11 and Hs3
are able to interact with other proteins, this can be explained
only if these proteins do not interact.
These results account for the lack of Sc3 complementation
by Hs3 in yeast, but do not explain the lack of Sc11 comple-
mentation by Hs11a protein [(4), and data not shown].
Two point mutants of Sc3 were isolated from a mutant
library which dramatically affect both Hs11a/Sc3 and
Hs11ba/Sc3 heterodimer formation (Figure 2, lines 10, 11,
18 and 19). In sharp contrast, those mutations do not affect
Sc11/Sc3 heterodimer formation (Figure 2, lines 2 and 3). One
mutant (L33F Q267Stop) demonstrates that the C-terminal
end of Sc3 is not required for Sc11/Sc3 interaction (Figure 2,
line 3). The two substitutions present in the other mutant
(G130E E208K) map are quite far from the interaction surface,
in agreement with the lack of effect on the Sc11/Sc3 hetero-
dimer formation (Figure 2, line 2). However, since Hs11ba
protein was shown to be able to functionally replace Sc11
in vivo (4), this indicates that the same residues of Sc3 may
not be identically involved in the interactions between this
subunit and the orthologous Sc11 and Hs11ba proteins.
Similarly, two point mutants of Hs3 were isolated that affect
the Hs3/Hs11 heterodimerisation to various extents. The
A40V substitution revealed the importance of the region
corresponding to the ﬁrst alpha helix, although it seemed to
affect lessthe Hs11a/Hs3 interactionthanthe Hs11ba/Hs3one
(Figure 2, compare lines 13 and 21), while other substitutions
such as E91K have little effect (Figure 2, lines 14 and 22).
Deletionofthe Hs3 C-terminalhelix (Q217Stop)abolishedthe
interaction in both cases (Figure 2, lines 15 and 23). This
observation is compatible with the 3D model established
for the yeast RNAP II, pointing towards the major interaction
surface between the Sc3 and Sc11 C-terminal helices
(Figure 1C).
TheroleoftheC-terminaldomainoftheRPB11-encoded
subunits
In order to elucidate the contributions of the various struc-
tural elements, we undertook a systematic deletion analysis of
RPB11-encoded subunits as depicted in Figure 3. Hs11a and
Hs11ba coding sequences were deleted for the residues cor-
responding to exon 4, thus retaining residues 1–106 and
1–105, respectively. Sc11 was deleted similarly (1–106).
The complete C-terminal helix was further deleted in mutants,
retaining residues 1–79, 1–79, 1–78 of Sc11, Hs11a and
Hs11ba, respectively. In addition, each C-terminal helix
was assayed on its own (80–120, 80–117, 79–115, for
Sc11, Hs11a and Hs11ba, respectively). Finally, chimeric
coding sequences were assayed, in which the very
C-terminal residues (from 107 to the end) were interchanged
between human and yeast proteins as depicted (Figure 3,
bottom).
Deletion of the complete C-terminal helix domain (as in
mutants 1–79 or 1–78) abolished the production of any
b-galactosidase activity (Figure 3, lines 3, 7, 11, 20, 24 and
28), suggesting that this domain is indispensible for the
Figure 2. InteractionsbetweenhumanandyeastRPB3mutants,andthehumanandyeastRPB11subunits.ThepeptidicsequenceofSc3isschematicallydepictedas
grey barswith the secondarystructureelements representedabove asin Figure1. Two mutantsare presented withthe pointmutations indicatedby verticalbars and
their name indicated on the left. The peptidic sequence of Hs3 is depicted as an opened bar together with three point mutants, as described above. The origin of the
codingsequencesinsertedintothepLexandpVPvectorsareindicatedonthetopandontheleft,respectively.BothrecombinantvectorsweretransformedintheL40
yeaststrain.Theresultingb-galactosidaseactivitywasmeasuredusingONPG(redbars,seeMaterialsandMethods)inindependentyeastcolonies(rightpanel).The
b-galactosidaseactivitiesgeneratedbytransformingthecellswiththepLex(lines8,16and24)andthepVPrecombinants(notshown)separatelyweresystematically
examined and found to be <10% of the highest value in each panel.
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domain is capable of interacting with Sc3 by itself
(80–120) to a signiﬁcant extent (Figure 3, lines 4). Similarly,
the (80–117) domain of Hs11a is able to interact with Hs3,
although very weakly (Figure 3, line 25). In contrast, however,
the (79–115) domain of Hs11ba shows no activity (Figure 3,
line 29). None of these human deletion mutants yielded any
detectable activity in the presence of the Sc3 ortholog
(Figure 3, lines 7, 8, 11 and 12). There is, therefore, a clear
species-speciﬁc restriction in the heterodimerization related
to this C-terminal domain.
We then investigated the contribution of the sequences cor-
responding to Hs11a and Hs11ba exon 4 or their equivalent in
Sc11.When assayed inthe presence ofHs3,the deletion ofthis
element in Hs11a and Hs11ba only moderately affects the
interaction between type 3 and 11 subunits (Figure 3, lines
22, 23 and 26, 27). In contrast, the same deletion of the Sc11
in the presence of Sc3 severely decreased this interaction
(Figure 3, lines 1 and 2).
All chimeras, in which the human or yeast sequences cor-
responding to exon 4 had been interchanged, showed reduced
interaction abilities when compared to the wild-type proteins
(Figure 3, compare lines 13–16 with 1, 5 and 9, or lines 30 and
31 with 22 and 26).
In the presence of Sc3, the Sc11-Hs11ba chimera yielded
an activity similar to that of the (1–106) deletion (Figure 3,
compare lines 2 and 16), suggesting that the sequences cor-
responding to human RPB11b exon 4 do not signiﬁcantly
contribute to the interaction, whereas the 107–117 residues
of Hs11a enhanced the observed activity (compare lines 2
and 15). Similarly, the fusion of the 107–120 residues of Sc11
partially restored the effect of the deletion of the human
C-terminal deletion (compare lines 6 and 10 with 13 and 14).
In contrast, in the presence of Hs3, these C-terminal Sc11
residues were unable to replace, even partially, their human
counterparts (Figure 3, compare lines 23 and 27 with lines 30
and 31).
Thus, it appears that the end of the C-terminal alpha helix of
Sc11 is more critical to the heterodimerization process in yeast
than the corresponding human domain.
The role of the a-motif of the RPB11-encoded subunits
In order to assess the contribution of the so-called ‘a-motif’ to
subunit heterodimerization, the conserved sequence was
examined in the context of the available 3D structure: three
residues (E, D and L, highlighted in yellow in Figure 1A)
were suspected to critically contribute to the interactions.
They were substituted by Ala residues and the effect of the
resulting mutations on heterodimerization is presented in
Figure 4.
Contrary to our expectations, alteration of these conserved
residues of Sc11 had no detectable effect on the heterodimer-
ization with Sc3 (Figure 4, compare lines 1–3). In sharp con-
trast, the mutation of the same residues of Hs11a and Hs11ba
strongly reduced the b-galactosidase activity in the presence
of Sc3, although the double mutant (ED) of Hs11ba had only a
2-fold effect (compare lines 4–9). In the human heterodimer,
however, the ED mutation of Hs11a and Hs11ba resulted in a
3-fold reduced activity. The additional L42A mutation did not
affect further the b-galactosidase activity in the case of Hs11a,
while the same mutation severely reduced the activity in the
case of Hs11ba, as in the presence of Sc3 (Figure 4, compare
lines 14–19).
Clearly, the a-motif seems to be differentially involved in
subunit heterodimerization, depending on its yeast or human
Figure 3. Interactions between the human and yeast RPB3 subunits, and deletion and recombinant mutants of human and yeast RPB11 subunits. The peptidic
sequenceofSc11anddeletionmutantsareschematicallydepictedasgreybarswiththesecondarystructureelementsrepresentedabove(seeFigure1).Thesequences
ofHs11aandHs11baanddeletionmutantsareshownbelowasopenbars,exceptforthepeptidesthatareencodedbytheexons4,showninblueandred,respectively.
The Lys 17 is missing in the h11ba protein, as figured by the small gap in the corresponding bars. Four chimeric coding sequences are presented below: the yeast
and human portions are shown with a code as above. The nature of the coding sequences inserted into the pLex and pVP vectors are indicated on the left and on the
top, respectively. Both recombinant vectors were transformed in the L40 yeast strain. The resulting b-galactosidase activity was measured using ONPG (red bars,
seeMaterialsandMethods)inindependentyeastcolonies(rightpanel).Theb-galactosidaseactivitiesgeneratedbytransformingthecellswiththepLex(lines17and
34) and the pVP recombinants (not shown) separately were systematically examined and found to be <10% of the highest value in each panel.
3586 Nucleic Acids Research, 2005, Vol. 33, No. 11origin. The requirement of this element actually appears to be
a speciﬁc property of the human RPB11-encoded subunits.
Sc11 C-terminal domain residues critical for
heterodimerization
The end of the C-terminal alpha helix of Sc11 appeared to
play an important role for the interaction with Sc3 (Figure 3).
The comparison of Sc11 with its ortholog from
Schizosaccharomyces pombe, which was shown to be able
to functionally replace Sc11 (11), indicated a conservation
for the EW and L residues at positions 108–111 (highlighted
in Figure 1A). We, therefore, decided to elucidate their res-
pective contributions to the Sc3/Sc11 interaction by studying
the effect of substituting them by Ala residues, either within
the context of the complete protein, or with the isolated
C-terminal domain (80–120) (Figure 5).
Both the triple (E18A,W109A,L111A) and single (W109A)
mutations of the full-length Sc11 proteins only slightly affec-
ted the efﬁciency of interaction with Sc3, as measured by
b-galactosidase activity (Figure 5, compare lines 1–3). In
contrast, the deletion of all residues beyond position 107
reduced the activity to 25% of the wild-type activity
(Figure 5, line 4, as in Figure 3, line 2).
The effect of the same mutations was strikingly different in
the isolated C-terminal domain (80–120), where both the triple
and the single (W109A) mutations completely abolished the
activity (lines 8 and 6), while the L111A mutation was still
able to interact with Sc3, although with a reduced efﬁciency
(line 7). The deletion of residues 107–120 abolished the
activity (lines 9). Therefore, residue W109 appears to be
chieﬂy involved in the Sc3/Sc11 interaction, whereas the
E108 and L111 residues only marginally contribute to
dimer formation.
Figure 4. Interactions between point mutants, affecting the a-motifs of human and yeast RPB11 subunits, and the human and yeast RPB3 subunits. The peptidic
sequenceofSc11andcorrespondingpointmutantsareschematicallydepictedasgreybarswiththesecondarystructureelementsrepresentedasabove(Figure1).The
sequencesofHs11aandHs11baare shownbelowasin Figure3togetherwithtwopointmutants.Thepositionsofthepointmutationsareindicatedbyverticalbars.
The origin of the coding sequences inserted into the pLex and pVP vectors are indicated on the left and on the top, respectively. Both recombinant vectors were
transformed in the L40 yeast strain. The resulting b-galactosidase activity was measured using ONPG (red bars, see Materials and Methods) in independent yeast
colonies (right panel). The b-galactosidase activities generated by transforming the cells with the pLex (lines 10 and 20) and the pVP recombinants (not shown)
separately were systematically examined and found to be <10% of the highest value in each panel.
Figure 5. InteractionsbetweenSc3andpointmutantsaffectingtheC-terminaldomainofSc11.ThepeptidicsequenceofSc11isschematicallydepictedasgreybars
withthesecondarystructureelements,representedasabove(Figure1),aswell asthreepointmutations(verticalbars).Thetestswereperformedanddescribedasin
Figure 2. The b-galactosidase activities generated by transforming the cells with the pLex (lines 10) and the pVP recombinants (not shown) separately were
systematically examined and found to be <10% of the highest value in each panel.
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Having established the contribution of the distinct elements
of Sc11 to its interaction with Sc3, we investigated their
importance in vivo by performing complementation assays
with either 2 mm or centromeric expression vectors (pGEN
and pCM, respectively). The viable complemented strains
were then assayed for temperature-sensitive phenotypes as
describedinFigure6A.Themoststrikingphenotypes obtained
are shown in Figure 6B.
Mutations E38A, D39A of the Sc11 ‘a-motif’ had essen-
tially no effect on yeast growth, whereas the triple alteration
(E38A,D39A,L42A) generated a very slight thermosensitivity
when expressed from the pGEN vector (Figure 6A). Mutation
W109A of the Sc11 C-terminal alpha helix had no effect in the
pGEN expression system, but showed a moderate temperature
sensitivity when expressed from the pCM vector. In contrast,
mutation L111A induced a very severe phenotype when
expressed from the pGEN vector, while it was lethal when
expressed from pCM (Figure 6A). The triple mutation
E108A,W109A, L111A produced a very similar phenotype,
although slightly weaker than the single mutation L111A
(Figure 6B, a and b). The combination of the E38A,D39A
and W109A mutations expressed from the pGEN elicited a
strong thermosensitivity, while the additional L42A mutation
generated a lethal phenotype, thus strongly supporting the
implication of these residues in an essential process in vivo
(Figure 6A).
In contrast, both double (E38A,D39A) and triple (E38A,
D39A,L42A) mutations of the ‘a-motif’ in Hs11ba abolished
viability of yeast cells, where this protein replaced Sc11.
Although cells harboring Hs11a in place of Sc11 were not
viable, the Hs11a-Sc11 chimeric subunit restored viability
(albeit with a strong thermosensitive phenotype), whether
expressed from either pGEN or pCM (Figure 6B, c).
DISCUSSION
A genetic assay to score protein interactions in yeast
We present a comparative analysis of the cross-
heterodimerization between yeast and human RPB3 and
RPB11encodedsubunits. This interactionislikelyto represent
Figure6.InvivoeffectsoftheRPB11mutations.(A)ThepeptidicsequenceofSc11andcorrespondingpointmutantsareschematicallydepictedasgreybarswiththe
secondary structureelements (Figure1). Thesequences ofHs11a andHs11ba are positionedbelowas in Figure3. The mutatedresidues are shownby vertical bars.
These coding sequences were inserted in two expression vectors, pGEN and pCM183, resulting in plasmids that were transformed in YGVS-072 yeast strains. The
resulting complemented strains exhibited phenotypes that are described in the table on the right. WT, SG, ts, TS, cs, CS stand for wild-type, slow growth, mild
thermosensitivity, strong thermosensitivity, mild cryosensitivity, strong cryosensitivity, respectively. N.D. indicates that the experiments has not been done.
(B) Growth of complemented yeast strains. RPB11 deleted yeast cells were complemented and the resulting strains were streaked on rich medium at various
temperatures, as indicated on the top right of each panel. The plasmids used for the complementation are indicated next to each streaked yeast strain.
3588 Nucleic Acids Research, 2005, Vol. 33, No. 11the initial assembly step of RNAP II in vivo (12,13). Although
the 3D structure of the yeast RNAP II has been established
(2,5), the functional importance of every potential contact
cannot be directly inferred from the model but requires experi-
mental validation. On the other hand, contacts critically
involved during subunit assembly may not be required in
the ﬁnal structure.
Hs3 subunit does not interact with Sc11 in yeast
As expected from partners within well characterized RNAP II
molecules, both human Hs3/Hs11a and yeast Sc3/Sc11
heterodimers were readily detectable using this two-hybrid
analysis, while under the same conditions Hs3/Sc11 hetero-
dimers could not be revealed. The incapacity of these fusion
proteins to interact is probably not related to some abnormal
behaviour, since both of them were able to interact with other
proteins. This lack of interaction actually accounts for the
inability of Hs3 to substitute for Sc3 in yeast (data not shown).
The Sc3/Hs11ba heterodimerization obeys rules
different from Sc3/Sc11
The Hs3/Hs11ba heterodimer appears to be as stable in yeast
cells asthe Hs3/Hs11a heterodimer. This observationindicates
that Hs11ba has the potential to integrate a bonaﬁde RNAP II
complex in a human cell, as suggested by the abilities for this
subunit,both to substitute forSc11 inyeast cells [(4), Figure 6]
and to interact with Sc3 with an efﬁciency similar to that of
Sc11 (Figure 2).
Surprisingly, however, we identiﬁed residues in Sc3 that
happenedtobecriticalforanefﬁcient interactionwithHs11ba
and Hs11a, while they had no effect on Sc3/Sc11 hetero-
dimerization (Figure 2). The Sc3/Hs11ba and the Sc3/Sc11
interactions, although both viable in yeast, seem therefore
to differ at the molecular level. This is further substantiated
by the observation that mutations affecting the ‘a-motif’ of
Sc11 had no detectable effect on the Sc3/Sc11 interaction,
although the same mutations of Hs11ba severely impaired
Sc3/Hs11ba heterodimerization (Figure 4). These residues
within the ‘a-motif’ of both Hs11a and Hs11ba human
proteins happened to be important for all the interactions
tested.
This observation is further conﬁrmed by the lack of a sig-
niﬁcant phenotype for the Sc11 mutants in vivo, although the
same mutations completely abolish the viability of Hs11ba
(Figure 6).
Specific functions are associated with the C-terminal
domain of RPB11 encoded subunits
Although Hs11a cannot substitute for Sc11 in yeast [(4),
Figure 6], it interacts with Sc3 just as well as Hs11ba,
which does complement. The failure of Hs11a to do so is,
therefore, probably related to the most C-terminal domain
of the protein, in keeping with the fact that the substitution
of this domain by the yeast equivalent (as in Hs11a-Sc11
chimera, see Figures 3 and 6) yields a protein which is able
to interact with Sc3 and is also viable in yeast. Critical func-
tions, which are not related to the ability of the subunits to
interact with Sc3, must therefore be linked to the C-terminal
domain in Sc11 and its human counterparts.
Deletion of the last 14 residues of C-terminal of Sc11
impairs more effectively its interaction with Sc3 than the
equivalent deletion of the human proteins Hs11a and
Hs11ba affects their interactions with Hs3 (Figure 3). In addi-
tion, the C-terminal alpha-helix of Sc11 interacts more efﬁ-
ciently with Sc3 than with Hs11a and Hs3 (Figure 3). This
Sc11 domain, therefore, appears to be much more involved in
the heterodimerization process, when compared to its human
counterparts. Indeed, the human heterodimers do not seem to
rely as much on this contact, since the deletion of the
sequences corresponding to exon 4 only moderately affects
the interaction with Hs3 (Figure 3).
A detailed analysis (Figure 5) of the importance of W109
and L111 of Sc11 in the heterodimerization indicated that their
respective contributions are in good agreement with the estab-
lished model for the complete RNAP II (2,5): W109 (whose
side chain points toward Sc3) was critical, whereas L111
(whose side chain protrudes from the complex) was dispens-
able, when assayed on the isolated domain.Inmarked contrast,
when assayed on cell growth, the contribution of W109 was
only marginal, while that of L111 turned out to be essential
(Figure 6A). An attractive explanation could be the interaction
of this Sc11 domain with an essential factor external to the
RNAP II complex. That W109 contributes to the stability of
the RNAP II complex in vivo may be inferred from the obser-
vation that the W109A mutation, which does not yield a strong
phenotype by itself, produces very severe phenotypes when
combined with the ‘a-motif’ mutations (Figure 6A). This
might be dueto the cumulative effects ofseparatesubstitutions
at the interface between Sc3 and Sc11, in agreement with the
established RNAP II model (2,5).
CONCLUSIONS
WedemonstratethattheSc3/Sc11andHs3/Hs11 heterodimers
are stabilized in distinct ways. Although some degree of con-
servation has been preserved, the same residues within the
conserved a-motif are differentially involved in the yeast
and human systems (Figure 7). The Sc3/Sc11 heterodimer
Figure 7. Summary of the identified contacts in the yeast and human subunits
and their contributions to the stability of the heterodimers. The subunits
sequences are schematically depicted, as in the previous figures. The contri-
butions of the homologous domains of Sc11, Hs11a and Hs11ba in the
heterodimerization with Sc3 and Hs3 subunits are represented by double-
headed arrows with thicknesses referring to the importance of the contacts.
Nucleic Acids Research, 2005, Vol. 33, No. 11 3589strongly depends on a speciﬁc C-terminal molecular motif, in
contrast to the Hs3/Hs11 heterodimers. This possibly allowed
the mammalian genomes to produce RPB11-encoded proteins
that exhibit various C-terminal domains, some of which being
restricted to human, without exceedingly affecting the het-
erodimerization process. It is, therefore, possible that
human-speciﬁc relationships have been established between
transcription and other cellular processes, during the course of
evolution. Indeed, severalproteins were describedto be able to
interact with the Hs11a (14,15) or with another variant,
Hs11bg (16), the physiological signiﬁcances of some interac-
tions being substantiated (17). It will be of utmost interest to
identify the functions associated with this C-terminal domain
both in yeast and human proteins. The identiﬁcation of all the
proteins able to interact with those domains in both systems
should be a ﬁrst step toward this goal.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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